Documentt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________________
Form 11-K
_________________________________________________________
| | | | | |
| x | ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2023
| | | | | |
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 001-35832
_________________________________________________________
| | | | | |
| A. | Full title of plan and the address of the plan, if different from that of the issuer named below: |
Science Applications International Corporation Retirement Plan
| | | | | |
| B. | Name of issuer of the securities held pursuant to the plan and the address of its principal executive office: |
Science Applications International Corporation
12010 Sunset Hills Road
Reston, VA 20190
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN
TABLE OF CONTENTS
| | | | | | | | |
| | Page |
| | |
| | 1 |
| | |
| FINANCIAL STATEMENTS | | |
| | 3 |
| | 4 |
| | 5 |
| | |
| SUPPLEMENTAL SCHEDULE | | |
| | 9 |
| | |
| | 10 |
| | |
| | 11 |
NOTE: All other schedules required by Section 29 CFR 2520.103-10 of the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974 have been omitted because they are not applicable.
Report of Independent Registered Public Accounting Firm
Plan Administrator and Plan Participants
Science Applications International Corporation Retirement Plan
Opinion on the financial statements
We have audited the accompanying statement of net assets available for benefits of Science Applications International Corporation Retirement Plan (the “Plan”) as of December 31, 2023, the related statement of changes in net assets available for benefits for the year ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2023, and the changes in net assets available for benefits for the year ended December 31, 2023 in conformity with accounting principles generally accepted in the United States of America.
Basis for opinion
These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
Supplemental information
The schedule of assets (held at end of year) as of December 31, 2023 (“supplemental information”) has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.
/s/ GRANT THORNTON LLP
We have served as the Plan’s auditor since 2024.
Jacksonville, Florida
June 20, 2024
Report of Independent Registered Public Accounting Firm
Plan Administrator and Plan Participants
Science Applications International Corporation Retirement Plan
Opinion on the Financial Statements
We have audited the accompanying statement of net assets available for benefits of the Science Applications International Corporation Retirement Plan (the “Plan”) as of December 31, 2022, and the related statement of changes in net assets available for benefits for the year then ended, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2022, and the changes in net assets available for benefits for the year then ended, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ Mayer Hoffman McCann P.C.
We served as the Plan's auditor from 2013 to 2023.
San Diego, California
June 29, 2023
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN
STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS
| | | | | | | | | | | | | | | | | | | | |
| | | | December 31, | | December 31, |
| | | | 2023 | | 2022 |
| | | | (in thousands) |
| ASSETS: | | | |
Investments, at fair value | $ | 4,963,065 | | | $ | 4,284,106 | |
| Receivables: | | | |
| Notes receivable from participants | 29,951 | | | 28,531 | |
| Employer contributions | 21,841 | | | 20,872 | |
| Participant contributions | — | | | 2 | |
| | Total receivables | 51,792 | | | 49,405 | |
| Total assets | 5,014,857 | | | 4,333,511 | |
| LIABILITIES: | | | |
| Excess contributions due to participants | 3 | | | 17 | |
| NET ASSETS AVAILABLE FOR BENEFITS | $ | 5,014,854 | | | $ | 4,333,494 | |
See accompanying notes to financial statements.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN
STATEMENTS OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS
| | | | | | | | | | | | | | | | | | | | |
| | | | Year Ended |
| | | | December 31, | | December 31, |
| | | | 2023 | | 2022 |
| | | | (in thousands) |
INVESTMENT INCOME (LOSS): | | | |
| Net appreciation (depreciation) in fair value of investments | $ | 678,105 | | | $ | (843,396) | |
| Interest and dividends | 69,992 | | | 60,960 | |
| | Net investment income (loss) | 748,097 | | | (782,436) | |
| | | | | | |
| INTEREST INCOME ON NOTES RECEIVABLE FROM PARTICIPANTS | 1,777 | | | 1,379 | |
| | | | | | |
| CONTRIBUTIONS: | | | |
| Participants | 216,566 | | | 209,933 | |
| Employer | 81,542 | | | 78,740 | |
| Participant rollovers | 41,811 | | | 35,101 | |
| | Total contributions | 339,919 | | | 323,774 | |
| | | | | | |
| DEDUCTIONS: | | | |
| Distributions paid to participants | 405,915 | | | 382,466 | |
| Administrative expenses | 2,518 | | | 2,304 | |
| | Total deductions | 408,433 | | | 384,770 | |
| | | |
INCREASE (DECREASE) IN NET ASSETS AVAILABLE FOR BENEFITS | 681,360 | | | (842,053) | |
| | | | | | |
| NET ASSETS AVAILABLE FOR BENEFITS: | | | |
| Beginning of year | 4,333,494 | | | 5,175,547 | |
| End of year | $ | 5,014,854 | | | $ | 4,333,494 | |
See accompanying notes to financial statements.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN
NOTES TO FINANCIAL STATEMENTS
December 31, 2023 and 2022
1. DESCRIPTION OF THE PLAN
The following brief description of the Science Applications International Corporation Retirement Plan (the “Plan”) is for general information purposes only. Participants should refer to the Plan document for complete information regarding the Plan. Within these financial statements, Science Applications International Corporation ("SAIC" or "Employer" or the “Company”) refers to the sponsoring employer.
General—The Plan is a defined contribution plan sponsored by the Company and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). The Plan is a 401(k) plan with profit-sharing and employee stock ownership plan (“ESOP”) features. Both employee and Company contributions to the Plan are held in a qualified retirement trust fund. The Science Applications International Corporation Benefit Plans Committee is the Plan’s named fiduciary for purposes of Section 402(a) of ERISA.
Eligibility—Employees of the Company are eligible to participate in the Plan. Employees must be in an eligible fringe benefit package to be eligible to receive Company matching 401(k) contributions. Generally, employees may make elective contributions and receive Company matching 401(k) contributions upon commencing employment.
Participant Contributions—The Plan permits participants to contribute up to 75% of their eligible compensation to the Plan, subject to statutory limitations. Participants may also contribute amounts representing rollovers from other qualified plans. Participant contributions are invested according to participant direction into any of the available investment funds of the Plan. Participant contributions and rollovers to the SAIC Common Stock Fund are limited to a maximum of 50% of the employee deferral or rollover, as applicable.
Employer Contributions—The Company may make matching 401(k) contributions. Eligible participants may receive Company matching 401(k) contributions based on a percentage (up to a maximum match percentage of 4%), depending on the fringe benefit package, which are invested per participant direction. The Company, at its discretion, may also make additional contributions to the Plan for the benefit of non-highly compensated participants in order to comply with Section 401(k) (3) of the Internal Revenue Code ("IRC"); however, the Company made no such additional contributions for the Plan years ended December 31, 2023 and 2022.
Participant Accounts—In accordance with Plan provisions, individual accounts are maintained for each Plan participant. Each participant’s account is credited with the participant’s contributions, and if eligible, allocations of Company contributions. Allocations are based on participant eligible compensation, as defined in the Plan document. Participant accounts also reflect changes from investment income and losses and from distributions. The benefit to which a participant is entitled is the vested balance of his or her account.
Investment Funds—As of December 31, 2023, the Plan held investments in 7 mutual funds, 21 collective trust funds, a self-directed brokerage fund, and 2 Company stock funds: the SAIC Common Stock Fund and the SAIC Closed Stock Fund (collectively, the “Stock Funds”). All amounts in the Stock Funds are invested in Science Applications International Corporation common stock, except for estimated cash reserves, which are invested in the Vanguard Federal Money Market Fund and are primarily used to provide future benefit distributions and facilitate investment exchanges.
Plan Amendments and Termination—Effective January 1, 2022, the Plan was amended and restated to incorporate all previous amendments and to make certain other changes regarding rollover contributions and benefit distributions.
Effective December 14, 2023, the Plan was amended to reflect the March 1, 2024 merger of the Koverse, Inc. 401(k) Plan with and into the Plan. This is in connection with the Company's acquisition of Koverse, Inc. during the year ended December 31, 2021. Certain other provisions were adopted to align Plan terms with prior operation regarding certain employees who received matching contributions in 2021 and 2022.
Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions and to terminate the Plan at any time subject to the provisions of ERISA.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN
NOTES TO FINANCIAL STATEMENTS
December 31, 2023 and 2022
Vesting and Forfeitures—Participants’ elective deferrals, rollover contributions and Company contributions together with associated earnings vest immediately. Unvested balances from other plans merged into the Plan in prior years continue to vest according to their original vesting schedules. Forfeitures are used to offset Company contributions or certain eligible Plan expenses. Forfeitures amounted to approximately $866,000 and $2,400,000 for the years ended December 31, 2023 and 2022, respectively. Forfeitures available for future use amounted to approximately $66,000 and $339,000 as of December 31, 2023 and 2022, respectively.
Notes Receivable from Participants—Participants may borrow up to 50% of their vested account balance, up to a maximum of $50,000 with a maximum of one outstanding loan per participant. Loan repayment periods may not exceed 60 months except for loans used to acquire a principal residence, in which case the repayment period may not exceed 30 years. The loans bear interest at a rate commensurate with local prevailing rates as determined monthly by the Plan administrator. Principal and interest are collected ratably through payroll deductions.
Distributions to Participants—For vested account balances less than $1,000, participants receive their vested account balance in a single lump sum following termination of employment with the Company. For vested account balances between $1,000 and $5,000, a participant’s vested account balance is automatically rolled over into an Individual Retirement Account following termination. For vested account balances that exceed $5,000, balances are not distributed unless the participant elects to take a distribution following the participant’s termination of employment with the Company. Regardless of the existing account balance, distributions are made when participants die or become permanently disabled while employed by the Company. After attaining the age of 59-1/2, a participant may make withdrawals even if still employed by the Company. Participants may make withdrawals from the Plan prior to attaining the age of 59-1/2 from their rollover account or if the participant incurs a financial hardship, as specified by the Plan document. Former employees, regardless of their age, may elect to receive up to two distributions in any given Plan year, of all or a portion of their account balance.
Tax Status—The Internal Revenue Service (“IRS”) has determined and informed the Company by a letter dated February 28, 2014, that the Plan was designed in accordance with the applicable requirements of the IRC. Although the Plan has been amended since receiving the determination letter, the Company believes that the Plan is designed, and is currently being operated, in compliance with the applicable requirements of the IRC and, therefore, believes that the Plan is qualified, and the related trust is tax-exempt. Accordingly, no provision for income taxes has been included in the Plan’s financial statements. Management recognizes tax liabilities for uncertainty in income taxes when it is more likely than not that a tax position would not be sustained upon examination by and settlement with the IRS. As of December 31, 2023 and 2022, there are no uncertain positions taken or expected to be taken that would require recognition of a liability or disclosure in the financial statements.
Related-Party Transactions—Certain Plan investments are managed by The Vanguard Group ("Vanguard") or an affiliate thereof. Vanguard is also the Plan’s record-keeper; therefore, transactions with these investments qualify as party-in-interest transactions. Members of the Science Applications International Corporation Benefit Plans Committee also participate in the Plan and qualify as parties-in-interest.
SAIC is the sponsoring employer as of December 31, 2023 and 2022. The value of SAIC shares held by the Plan in the Stock Funds was approximately $127,903,000 and $119,474,000 as of December 31, 2023 and 2022, respectively. For the years ended December 31, 2023 and 2022, the Stock Funds earned dividends of approximately $1,559,000 and $1,678,000 and appreciated in value by approximately $13,607,000 and $25,826,000, respectively.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN
NOTES TO FINANCIAL STATEMENTS
December 31, 2023 and 2022
2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Accounting—The Plan’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
Investment Valuation and Income Recognition—Investments held by the Plan are carried at fair value. There have been no changes in investment valuation methodologies. Valuation and income recognition policies are as follows:
Investment in Mutual Funds—The Plan’s investments in mutual funds are stated at fair value based on quoted market prices.
Investment in Collective Trusts—The Plan's investments in collective trusts are carried at net asset value (“NAV”) per unit as a practical expedient to estimate fair value, which is determined by the trustee using the fair value of the underlying investments.
Investment in Common Stock—Investments in shares of SAIC common stock are recorded at their last quoted market price on the last business day of the respective plan year. SAIC shares were publicly traded on the New York Stock Exchange through the year ended December 31, 2023, subsequently moving to the NASDAQ in 2024.
Self-Directed Brokerage Fund—The Plan’s investments in the self-directed brokerage fund are stated at fair value based on quoted market prices.
Investment Gains and Losses—Realized gains and losses on sales of investments are calculated as the difference between the fair value of the investments upon sale and the fair value of the investments at purchase. Unrealized appreciation or depreciation is calculated as the difference between the fair value of the investments at the end of the year and the fair value of the investments at the beginning of the year or on the date of purchase if purchased during the year. Interest income is recorded as earned, and dividends are recorded on the ex-dividend date.
Investment Risks and Uncertainties—The Plan invests in various investment securities which, in general, are exposed to various risks, such as interest rate risk, credit risk, and overall market volatility. Due to the level of risk associated with investment securities, it is reasonably possible that changes in the values of certain investment securities will occur in the near term and such changes could materially affect the amounts reported in the statement of net assets available for benefits and statement of changes in net assets available for benefits.
Notes Receivable from Participants—Notes receivable from participants are carried at the aggregate unpaid principal balance, plus accrued, unpaid interest of loans outstanding. If a participant defaults on a loan, it becomes a distribution from the Plan to the participant.
Distributions Paid to Participants—Benefit payments to participants are recorded upon distribution. There were no distributions payable to participants who had elected to withdraw from the Plan but had not yet been paid as of December 31, 2023 and 2022.
Use of Estimates—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of additions and deductions during the reporting periods. Actual results may differ from those estimates.
Administrative Expenses—Administrative expenses of the Plan are paid by the Plan sponsor or Plan participants as provided in the Plan document. Payments for service fees, professional fees, and plan-related investment advisory fees are generally funded from assessments charged on participant accounts.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN
NOTES TO FINANCIAL STATEMENTS
December 31, 2023 and 2022
3. FAIR VALUE MEASUREMENTS
Accounting guidance has been issued that establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels of the fair value hierarchy are described below:
Level 1 Unadjusted quoted prices for identical assets or liabilities in active markets that the Plan has the ability to access.
Level 2 Inputs to the valuation methodology include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in inactive markets; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the Level 2 inputs must be observable for substantially the full term of the asset or liability.
Level 3 Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
The following table sets forth the Plan’s investments at fair value and by level, as applicable, as of December 31, 2023 and 2022:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Level 1 | | Total |
| | 2023 | | 2022 | | 2023 | | 2022 |
| | (in thousands) |
| Mutual funds | | $ | 1,380,262 | | | $ | 1,240,773 | | | $ | 1,380,262 | | | $ | 1,240,773 | |
SAIC common stock | | 127,903 | | | 119,474 | | | 127,903 | | | 119,474 | |
| Self-directed brokerage fund | | 86,276 | | | 65,925 | | | 86,276 | | | 65,925 | |
| Subtotal | | $ | 1,594,441 | | | $ | 1,426,172 | | | $ | 1,594,441 | | | $ | 1,426,172 | |
Collective trusts—measured at NAV | | 3,368,624 | | | 2,857,934 | |
| Total | | | | | | $ | 4,963,065 | | | $ | 4,284,106 | |
Collective trusts are measured at fair value using NAV as a practical expedient for fair value and have not been categorized in the fair value hierarchy. The fair value amounts presented in the table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Statements of Net Assets Available for Benefits. The Plan has no unfunded commitments to the collective trusts, and there are no redemption restrictions. There were no Level 2 or Level 3 investments as of December 31, 2023 and 2022.
4. SUBSEQUENT EVENTS
In preparing the accompanying financial statements, management of the Plan has evaluated all subsequent events and transactions for potential recognition or disclosure through June 20, 2024, the date the financial statements were issued.
On March 1, 2024, the Koverse, Inc. 401(k) Plan was merged into the Plan as discussed in Note 1. Assets totaling approximately $3,300,000 were transferred into the Plan.
******
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN
SUPPLEMENTAL SCHEDULE
FORM 5500, SCHEDULE H, PART IV, LINE 4i—SCHEDULE OF ASSETS (HELD AT END OF YEAR)
AS OF DECEMBER 31, 2023
| | | | | | | | | | | | | | | | | | | | | | | |
| | | EIN: 30-6419427 | | Plan #001 |
| Identity of Issue, Borrower, Lessor, or Similar Party | | Description of Investment Including Maturity Date, Rate of Interest and Collateral | | Cost | | Current Value |
| | | | | (in thousands) |
| * | Science Applications International Corporation common stock | | Company Stock | | ** | | $ | 127,903 | |
| Dodge & Cox Stock Fund Class X | | Mutual Fund | | ** | | 235,591 |
| T. Rowe Price Institutional Mid Cap Equity Growth Fund | | Mutual Fund | | ** | | 153,887 |
| * | Vanguard FTSE All-World ex-US Index: Institutional Shares | | Mutual Fund | | ** | | 187,905 |
| * | Vanguard Federal Money Market Fund | | Mutual Fund | | ** | | 276,996 |
| * | Vanguard International Growth Fund Admiral Shares | | Mutual Fund | | ** | | 123,481 |
| * | Vanguard PRIMECAP Fund Admiral Shares | | Mutual Fund | | ** | | 361,933 |
| * | Vanguard Short-Term Bond Index Fund Institutional | | Mutual Fund | | ** | | 40,469 |
| Columbia Trust Emerging Markets Equity Fund; Founders Cl | | Collective Trust | | ** | | 35,614 |
| Loomis Sayles Core Plus Fixed Income Trust Class C | | Collective Trust | | ** | | 73,785 |
| T.Rowe Price Large Cap Growth Class L | | Collective Trust | | ** | | 16,756 |
| T. Rowe Price U.S. Mid Cap-Value Equity Trust; D Class | | Collective Trust | | ** | | 56,666 |
| * | Vanguard Institutional 500 Index Trust | | Collective Trust | | ** | | 732,648 |
| * | Vanguard Institutional Extended Market Index Trust | | Collective Trust | | ** | | 225,996 |
| * | Vanguard Institutional Total Bond Market Index Trust | | Collective Trust | | ** | | 221,321 |
| * | Vanguard Target Retirement 2020 Trust Plus | | Collective Trust | | ** | | 172,327 |
| * | Vanguard Target Retirement 2025 Trust Plus | | Collective Trust | | ** | | 317,404 |
| * | Vanguard Target Retirement 2030 Trust Plus | | Collective Trust | | ** | | 365,631 |
| * | Vanguard Target Retirement 2035 Trust Plus | | Collective Trust | | ** | | 261,464 |
| * | Vanguard Target Retirement 2040 Trust Plus | | Collective Trust | | ** | | 208,354 |
| * | Vanguard Target Retirement 2045 Trust Plus | | Collective Trust | | ** | | 180,378 |
| * | Vanguard Target Retirement 2050 Trust Plus | | Collective Trust | | ** | | 131,469 |
| * | Vanguard Target Retirement 2055 Trust Plus | | Collective Trust | | ** | | 73,369 |
| * | Vanguard Target Retirement 2060 Trust Plus | | Collective Trust | | ** | | 39,688 |
| * | Vanguard Target Retirement 2065 Trust Plus | | Collective Trust | | ** | | 12,763 |
| * | Vanguard Target Retirement 2070 Trust Plus | | Collective Trust | | ** | | 1,118 |
| * | Vanguard Target Retirement Income Trust Plus | | Collective Trust | | ** | | 108,014 |
| Wellington Trust Small Cap 2000 | | Collective Trust | | ** | | 114,086 |
| Wellington Trust TIPS | | Collective Trust | | ** | | 19,773 |
| Self-Directed Brokerage Fund | | Various | | ** | | 86,276 |
| * | Notes Receivable from Participants | | Loans/Interest rates from 4.25% to 9.50%; maturities from January 2024 to November 2053 | | ** | | 29,951 |
| Total | | | | | | $ | 4,993,016 | |
| | | | | | | |
| * | Indicates party-in-interest to the Plan | | | | | | |
| ** | Not applicable - Historical cost information is not required to be presented, as all investments are participant-directed. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Science Applications International Corporation Benefit Plans Committee has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
By: Science Applications International Corporation Benefit Plans Committee
| | | | | | | | | | | |
Date: June 20, 2024 | | | /s/ Paul C. Lehrer |
| | | Paul C. Lehrer |
| | | Authorized Official |
| | | Science Applications International Corporation |
Exhibit Index
| | | | | | | | |
| Exhibit No. | | Description of Exhibit |
| | |
| | |
| | |